Similac Probiotic Tri-Blend — Class II food recall F-0328-2024
Terminated recall by Abbott Laboratories, reported 2023-11-15, distributed in AL, AR, AZ, CA, CO, CT, FL, GA…. Marketed towards preterm infants without approval as a new drug or licensed biologic, as well as unsafe food a
| Recall number | F-0328-2024 |
|---|---|
| Product type | Food |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abbott Laboratories, Columbus, OH, United States |
| Recall initiated | 2023-10-31 |
| Classified | 2023-11-07 |
| Reported by FDA | 2023-11-15 |
| Terminated | 2024-09-03 |
| Distributed | AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV |
| Countries outside the US | MX |
| Lot numbers | 45002IP |
| Expiration dates | 2024-09-01 |
Product
Similac Probiotic Tri-Blend - 0.017oz (0.50g) packaged in foil packets. 50 foil packets per carton - 3 cartons per case.
Reason for recall
Marketed towards preterm infants without approval as a new drug or licensed biologic, as well as unsafe food additive
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-0328-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.